SRP-4045

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRP-4045, covering 2021-05-17 to 2021-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients [Phase 1]

See pricing